Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets committed to tackling AMR, says BVA
pills
BVA says it is "not complacent" about the role of veterinary medicine in AMR.
BVA updates MPs on plans to tackle antibiotic resistance

Former president of the BVA, Peter Jones, yesterday reassured parliamentarians that vets are committed to the fight against antimicrobial resistance (AMR).

Appearing before the All Party Parliamentary Group (APPG) on antibiotics, Mr Jones said the veterinary profession remains committed to one health and "the need for the medical and veterinary professions to work together to tackle AMR."

While the biggest cause of human resistance is the overuse and misuse of antibiotics in human medicine, the BVA is "not complacent" about the part played by antibiotic use in veterinary medicine.

Along with its specialist divisions, the BVA is working on a plan to deliver the government's five-year AMR strategy from a veterinary perspective.

“One of our key aims for the strategy will be to promote the importance of evidence-based responsible use among both vets and their clients," Mr Jones explained.

"We are already encouraging education on minimising resistance and principles of responsible use through engagement with the veterinary schools and other stakeholders, and through our own continuing professional development (CPD) programme."

The BVA is also updating its responsible use guidance for the profession, while the association's species divisions continue their work on tailoring advice to particular sectors.

It has agreed in principle to the recording and reporting of antibiotic use and will consider how to encourage this, as well as how to measure and admit usage and how to assess prescribing habits.

Such measures will allow resistance development and any progress made in addressing the problem to be tracked.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.